Prospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Aug 28, 2025; 31(32): 110333
Published online Aug 28, 2025. doi: 10.3748/wjg.v31.i32.110333
Table 3 Budget impact analysis
Parameter
Y1
Y2
Y3
Y4
Y5
Total
Total population2134883121348831
New population10284311011655103324510464814119812
Patients with DM211353493319179937594952150915
Patients evaluated with scoring system190218183988261843885461935824
FIB-4 + TE
Patients with FIB-4 ≥ 1.3100419329902941300430421016170
Patients undergo TE9037742691264727032738914553
Total BIA, THB (USD)2323021957
(67062996)
7657269
(221057)
7532362
(217451)
7693112
(222091)
7791661
(224936)
2353696361
(67948531)
Average annual budget, THB (USD)470739272
(13589706)
SAFE + TE
Patients with SAFE ≥ 0168783573387219737374671717232
Patients undergo TE151905266046497663567201545509
Total BIA, THB (USD)3714212955
(107225095)
16194000
(467502)
15929840
(459876)
16269803
(469691)
16478221
(475707)
3779084819
(109097872)
Average annual budget, THB (USD)755816964
(21819574)
TE alone
Patients undergo screening169082774657343750075961720732
Total BIA, THB (USD)3381654830
(97624521)
14930254
(431019)
14686708
(423989)
15000141
(433037)
15192295
(438584)
3441464227
(99351150)
Average annual budget, THB (USD)688292845
(19870230)